Tag: Acarix

Acarix two largest shareholders transfer subscription rights free of charge – extends the subscription period

Press release Malmö, September 2, 2020   Acarix two largest shareholders transfer subscription rights free of charge –extends the subscription period The Extraordinary General Meeting of Acarix AB (“Acarix” or the “Company”) resolved on 11 August 2020, subsequent to the board of directors resolution on 15 July 2020, to approve […]

Last patient included in Acarix’s exploratory heart failure study SEISMO

Malmö, Sweden May 11, 2020 Last patient included in Acarix’s exploratory heart failure study SEISMO Acarix AB (publ) today announced that the last patient has been included in the exploratory SEISMO study on a potential heart failure application. The exploratory clinical heart failure trial SEISMO was initiated in June 2018 to evaluate the possibility […]

First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients

Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients Acarix AB (publ) today announced the initiation of the randomized, multi-center clinical study FILTER-SCAD to examine the cost effectiveness and safety of adding the CADScor®System as a rule-out test in patients referred with symptoms […]

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB (“Acarix” or the “Company”) has today, pursuant to the authorization granted by the extra general meeting on 16 August 2019, resolved to […]

CADScor®System – Significantly more effective than current practice

Malmö August 5, 2019 CADScor®System – Significantly more effective than current practice Acarix AB (publ) (ACARIX: FN Stockholm) today announced the publication of a meta-analysis including 2245 patients showing Acarix’s leading CADScor®System is more than three times as effective as current practice, implying clinical and economic advantages.  “Strong clinical evidence […]

Customer evaluation of CADScor®System compares favorably against existing methods

Interim Report, January – September 2018 Malmö, November 14, 2018 Customer evaluation of CADScor®System compares favorably against existing methods “During the quarter we proudly reported that Kristianstad Central Hospital in Sweden evaluated the CADScor®System with a positive outcome. Due to the good result the hospitals clinical management team has now […]